Asger Wretlind

444 total citations
10 papers, 121 citations indexed

About

Asger Wretlind is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Asger Wretlind has authored 10 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Asger Wretlind's work include Metabolomics and Mass Spectrometry Studies (4 papers), Diabetes Treatment and Management (3 papers) and Cholesterol and Lipid Metabolism (2 papers). Asger Wretlind is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (4 papers), Diabetes Treatment and Management (3 papers) and Cholesterol and Lipid Metabolism (2 papers). Asger Wretlind collaborates with scholars based in Denmark, United Kingdom and United States. Asger Wretlind's co-authors include Cristina Legido‐Quigley, Latha Velayudhan, Jin Xu, Petroula Proitsi, Tommi Suvitaival, Peter Rossing, Viktor Rotbain Curovic, Min Kim, Jodie Lord and Tine W. Hansen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Diabetes.

In The Last Decade

Asger Wretlind

10 papers receiving 121 citations

Peers

Asger Wretlind
Andrea Llano United Kingdom
Amber S. Shun-Shion United Kingdom
Judit Barta Hungary
Rebecca Gelfer United States
Alexander M. Roche United States
R. J. Hunter United Kingdom
Lucydalila Cedillo United States
Andrea Llano United Kingdom
Asger Wretlind
Citations per year, relative to Asger Wretlind Asger Wretlind (= 1×) peers Andrea Llano

Countries citing papers authored by Asger Wretlind

Since Specialization
Citations

This map shows the geographic impact of Asger Wretlind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asger Wretlind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asger Wretlind more than expected).

Fields of papers citing papers by Asger Wretlind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asger Wretlind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asger Wretlind. The network helps show where Asger Wretlind may publish in the future.

Co-authorship network of co-authors of Asger Wretlind

This figure shows the co-authorship network connecting the top 25 collaborators of Asger Wretlind. A scholar is included among the top collaborators of Asger Wretlind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asger Wretlind. Asger Wretlind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wretlind, Asger, Wenqiang Chen, Latha Velayudhan, et al.. (2025). Lipid profiling reveals unsaturated lipid reduction in women with Alzheimer's disease. Alzheimer s & Dementia. 21(8). e70512–e70512. 1 indexed citations
2.
Xu, Jin, Anja Hviid Simonsen, Asger Wretlind, et al.. (2023). Human Cerebrospinal Fluid Sample Preparation and Annotation for Integrated Lipidomics and Metabolomics Profiling Studies. Molecular Neurobiology. 61(4). 2021–2032. 3 indexed citations
3.
Wretlind, Asger, Viktor Rotbain Curovic, Tommi Suvitaival, et al.. (2023). Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes. Diabetes. 72(10). 1493–1501. 13 indexed citations
4.
Wretlind, Asger, Viktor Rotbain Curovic, Andressa de Zawadzki, et al.. (2023). Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials. Lipids in Health and Disease. 22(1). 160–160. 9 indexed citations
5.
Wretlind, Asger, Emilie H. Zobel, Andressa de Zawadzki, et al.. (2022). Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial. SHILAP Revista de lepidopterología. 3. 856485–856485. 2 indexed citations
6.
Zawadzki, Andressa de, Maja Thiele, Tommi Suvitaival, et al.. (2022). High-Throughput UHPLC-MS to Screen Metabolites in Feces for Gut Metabolic Health. Metabolites. 12(3). 211–211. 3 indexed citations
7.
Akalestou, Elina, Livia López–Noriega, Eleni Georgiadou, et al.. (2021). Intravital imaging of islet Ca2+ dynamics reveals enhanced β cell connectivity after bariatric surgery in mice. Nature Communications. 12(1). 5165–5165. 22 indexed citations
8.
Zobel, Emilie H., Asger Wretlind, R Ripa, et al.. (2021). Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial. BMJ Open Diabetes Research & Care. 9(1). e002395–e002395. 22 indexed citations
9.
Xu, Jin, Min Kim, Asger Wretlind, et al.. (2020). Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease. Translational Neurodegeneration. 9(1). 36–36. 44 indexed citations
10.
Wretlind, Asger, et al.. (1957). Erfahrungen über intravenöse Fettemulsionen. Langenbeck s Archives of Surgery. 287(1). 486–489. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026